Friday’s trading saw an interesting pattern form on consumer staple stock Colgate-Palmolive (NYSE: CL). The pattern is known as a shooting star pattern in candlestick charting and it is considered a bearish reversal pattern.
What happens with a shooting star is that the stock opens slightly higher, jumps considerably higher during the day, and then falls to close at a similar level that it opened at.
The thinking behind the pattern is that the bulls have been in control and have driven the stock price higher. The bulls are in control on the day in question, but at some point during the day the bears seize control and drive the price down. Here is what it looks like on Colgate-Palmolive’s chart.
We see that the stock moved higher from the December 26 low, jumping from down close to $57 and moved above $63 on Friday. The stock opened at $62.01 on Friday, jumped to a high of $63.27, but closed at $62.21. This meets the definition of a shooting star pattern.
What is particularly interesting about Colgate-Palmolive is that the company is set to release earnings on Friday, January 25. When the company reported earnings back on October, the stock gapped sharply lower after the earnings disappointed investors. The earnings per share missed estimates. The company did see earnings and sales decline in the most recent quarterly report.
CL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where CL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on October 25, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CL as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CL turned negative on October 25, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
CL moved below its 50-day moving average on October 01, 2024 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CL crossed bearishly below the 50-day moving average on October 01, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CL entered a downward trend on October 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (120.482) is slightly higher than the industry average of (16.756). P/E Ratio (32.152) is within average values for comparable stocks, (199.024). Projected Growth (PEG Ratio) (2.232) is also within normal values, averaging (3.746). Dividend Yield (0.022) settles around the average of (0.106) among similar stocks. P/S Ratio (3.795) is also within normal values, averaging (112.094).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of oral, personal, and household products
Industry HouseholdPersonalCare